Altitude Life Science Ventures logo

Altitude Life Science Ventures

North America, Colorado, United States, Durango

Description

Philosophy is to focus on life science markets with strong demand and growth potential, and then back the highest-quality entrepreneurs in

Investor Profile

Altitude Life Science Ventures has made 48 investments, with 2 in the past 12 months and 4% as lead.

Stage Focus

  • Series B (33%)
  • Series A (27%)
  • Series C (23%)
  • Series Unknown (6%)
  • Series D (4%)
  • Post Ipo Equity (4%)
  • Seed (2%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Life Science
  • Pharmaceutical
  • Biopharma
  • Genetics
  • Nanotechnology
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Altitude Life Science Ventures frequently co-invest with?

Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 8
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 4
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 8
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 5
The Column Group
North America, California, United States, San Francisco
Co-Investments: 7
Venrock
North America, California, United States, Palo Alto
Co-Investments: 5
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 8
Invus
North America, New York, United States, New York
Co-Investments: 6
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 29

Which angels does Altitude Life Science Ventures often collaborate with?

David Pyott
North America, California, United States, Orange
Shared Deals: 1
MZ
North America, United States
Shared Deals: 1

What are some of recent deals done by Altitude Life Science Ventures?

Lila Sciences

Cambridge, Massachusetts, United States

Lila Sciences creates a scientific superintelligence platform and autonomous labs for life sciences, chemistry, and materials science.

Artificial Intelligence (AI)Life ScienceSoftware
SeedMar 10, 2025
Amount Raised: $200,000,000
Vilya

Seattle, Washington, United States

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.

BiotechnologyHealth DiagnosticsLife ScienceMedical
Series AJun 4, 2024
Amount Raised: $21,000,000
Ring Therapeutics

Cambridge, Massachusetts, United States

Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.

BiotechnologyHealth CareTherapeutics
Series CMar 9, 2023
Amount Raised: $86,500,000
Escient Pharmaceuticals

San Diego, California, United States

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series CNov 28, 2022
Amount Raised: $120,000,000
Neumora Therapeutics

Watertown, Massachusetts, United States

Neumora Therapeutics operates as a clinical-stage biotechnology company.

BiotechnologyHealth CareMedical
Series BOct 11, 2022
Amount Raised: $112,000,000
Tessera Therapeutics

Cambridge, Massachusetts, United States

Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.

BiopharmaBiotechnologyGeneticsLife ScienceTherapeutics
Series CApr 19, 2022
Amount Raised: $300,000,000
Ansa Biotechnologies

Emeryville, California, United States

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

BiotechnologyLife ScienceTherapeutics
Series AApr 11, 2022
Amount Raised: $68,000,000
Generate Biomedicines

Somerville, Massachusetts, United States

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

BiotechnologyHealth CareMedicalProduct Research
Series BNov 18, 2021
Amount Raised: $370,000,000
Mozart Therapeutics

Seattle, Washington, United States

Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.

Biotechnology
Series AOct 26, 2021
Amount Raised: $55,000,000
Neumora Therapeutics

Watertown, Massachusetts, United States

Neumora Therapeutics operates as a clinical-stage biotechnology company.

BiotechnologyHealth CareMedical
Series AOct 7, 2021
Amount Raised: $400,000,000